The Patent Finder

Les Laboratoires Servier

69 patents currently held · Updated Nov 16, 2026
31 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 11 name spellings.

19
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 6 fees due Feb 13 to 25, 2027 · next Feb 13
  • 2 fees due Mar 1 to 17, 2027 · next Mar 1
  • 1 fee due Apr 22, 2027
    The maintenance fee for Anti-MET antibodies and compositions (US 10,450,376) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
  • 1 fee due May 7, 2027
    The maintenance fee for Anti-AXL antibodies and compositions (US 11,807,688) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same (US 11,833,162) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 1 fee due Sep 26, 2027
    The maintenance fee for Combination Therapies Targeting PD-1, TIM-3, and LAG-3 (US 11,939,380) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026
  • 4 terms have ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,867,996γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,479,569Process for the synthesis of (7-methoxy-3,4-dihydro-1-naphthalenyl) acetonitrile and its application in the synthesis of agomelatine
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,867,994Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,960,438Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,923,569β Crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,846,961α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,414,896Recombinant anti-epidermal growth factor receptor antibody compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,887,805Recombinant anti-epidermal growth factor receptor antibody compositions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,283,294Method for cloning cognate antibodies
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,404,742Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 69 patents shown.
Pro members see all 69.
Pro members: see all 69 patents
Also on record, not counted in the 69: 31 patents in force now held by others · 298 lapsed for an unpaid fee · 172 ended at full term · 1 past the fee grace period · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

23 pending · 13 abandoned · 89 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited